Karla Gorio
Medical · Baton Rouge, LANPI 1750613345
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,192 of the $8,659 with a category attached, or 83.1%. 38 manufacturers reported payments, led by Abbott at 30.3% of the total. Among medical clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 387 payments — averaging $22.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$799
- Novartis$624
- Johnson & Johnson$518
- Merck$501
- Amgen$323
- plus $3K from 32 others
What the payments were for
- Travel & lodging$1,46717%
- Food & beverage$7,19283%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 43 | $2,621 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 27 | $799 |
| Novartis | 45 | $624 |
| Johnson & Johnson | 33 | $518 |
| Merck | 30 | $501 |
| Amgen | 28 | $323 |
| Pfizer | 17 | $302 |
| Esperion Therapeutics, Inc. | 20 | $291 |
| Bayer | 16 | $280 |
| Boehringer Ingelheim | 18 | $271 |
| E.r. Squibb & Sons, L.L.C. | 19 | $268 |
| Amarin Pharma, Inc. | 14 | $244 |
| Inari Medical, Inc. | 2 | $208 |
| Daiichi Sankyo Inc. | 10 | $200 |
| Sanofi-aventis U.S. LLC | 10 | $166 |
| Scpharmaceuticals Inc. | 9 | $156 |
| AstraZeneca | 10 | $134 |
| Novo Nordisk | 7 | $130 |
| Medtronic | 3 | $76 |
| Boston Scientific | 3 | $74 |
| Itamar Medical Inc | 2 | $61 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $48 |
| Actelion Pharmaceuticals US, Inc. | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 2 | $40 |
| Cvrx, Inc. | 1 | $34 |
| Mannkind Corporation | 1 | $27 |
| Edwards Lifesciences | 1 | $25 |
| Stryker | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Philips North America LLC | 1 | $20 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
| Biogen | 1 | $17 |
| GSK | 1 | $17 |
| Impulse Dynamics (USA) Inc. | 1 | $16 |
| Abiomed | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Kestra Medical Technology Services, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CARDIOMEMS$1,425
- FLOWTRIEVER CATHETER, S$199
- CT THROMBECTOMY SYSTEM KIT$199
- JOT DX$178
How this compares
$8,659 in reported general payments places this provider in the 95th percentile of 253 medical providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 74 | $59,883 |
| EntrestoSacubitril/Valsartan | 78 | $56,205 |
| FarxigaDapagliflozin Propanediol | 26 | $31,135 |
| Repatha SureclickEvolocumab | 16 | $13,035 |
| JardianceEmpagliflozin | 14 | $10,699 |
| VerquvoVericiguat | 11 | $8,789 |
| XareltoRivaroxaban | 11 | $8,631 |
| Metoprolol Succinate | 166 | $1,264 |
| Amiodarone Hcl | 37 | $1,050 |
| Ezetimibe | 18 | $419 |
| Atorvastatin Calcium | 37 | $392 |
| Nifedipine ErNifedipine | 26 | $387 |
| Midodrine Hcl | 12 | $326 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 39 | $310 |
| Torsemide | 13 | $267 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $302 | $59,88374 claims |
| NovartisEntresto | $624 | $56,20578 claims |
| AstraZenecaFarxiga | $134 | $31,13526 claims |
| Boehringer IngelheimJardiance | $271 | $10,69914 claims |
| MerckVerquvo | $501 | $8,78911 claims |
| Johnson & JohnsonXarelto | $518 | $8,63111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 253 medical providers in Louisiana.
Other medical in Baton Rouge
- Kristi RobertBaton Rouge$486K
- Vickie RiceBaton Rouge$19K
- Emily FerraraBaton Rouge$9K
- Kimberly BergeronBaton Rouge$7K
- Brittany HallBaton Rouge$6K
- Rebecca LandryBaton Rouge$5K
- Connie BrunsonBaton Rouge$5K
- Lindsay BrunsonBaton Rouge$5K
- Jessica TempletBaton Rouge$5K
- Brooke VincentBaton Rouge$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.